You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY22 is not expected to be complete until September, 2023.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
-
Peptide Based Therapy for Lung Fibrosis
SBC: Novici Biotech LLC Topic: NHLBIDESCRIPTION provided by applicant Fibroproliferative illnesses leading to organ fibrosis and failure are responsible for approximately of deaths in developed countries whether idiopathic triggered by environmental factors infections or genetics organ fibrosis results in significant morbidity and mortality Organ fibrosis is responsible for health care costs exceeding $ billion year ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Real-Time Oxygen Monitoring for Tissue Health: Peripheral Artery Disease Application
SBC: PROFUSA, INC. Topic: NHLBIDESCRIPTION provided by applicant Continuous biochemical monitoring has the power to change currently accepted standards of care shifting the emphasis from treating illness to maintaining health Point in time snapshots of a patientandapos s health can miss critical fluctuations or early warning signs that might warrant early interventions or changes in disease treatment and management PROFUS ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Lowering the Cost of Imaging for Retinal Microvasculature in Diabetic Patients
SBC: AEON IMAGING LLC Topic: WDESCRIPTION provided by applicant Recently we found extensive remodeling of the microvasculature of the retina occurring in some diabetic patients much earlier than expected This provides the potential for novel biomarkers However the equipment is too expensive for most clinics and small practices These early retinal microvascular changes cannot be seen with routine clinical examination o ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
A Visual Assessment System for Retinal Function/Drug Discovery
SBC: AFASCI INC Topic: NDESCRIPTION provided by applicant Preclinical evaluation of treatment strategies for retinal neurodegenerative diseases is highly dependent on mouse models Classical methods to assess the visual function of animals such as electroretinogram ERG which measures electrical responses in the retina do not address connections between the eye and brain or visual perception by the visual system ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Macromolecule Crystallization Screening Results Analysis
SBC: iXpressGenes, Inc. Topic: 100DESCRIPTION provided by applicant Crystallization followed by subsequent structure determination is a major step in understanding the structure function relationship of macromolecules Understanding macromolecule structure has become a key part in the development of new pharmaceuticals and is a major area of NIH research Crystallization however is also the rate limiting step despite techno ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Paper-based Rapid Diagnostics for Early Dental Caries Prediction at the Chairside
SBC: PHASE DIAGNOSTICS LLC Topic: NIDCRDESCRIPTION provided by applicant Dental caries is the single most common affliction across the globe affecting billion people The current process of identifying dental caries involves examining caries formation by naked eyes or X ray during routine checkups Once identified surgical restorative procedures are used to drill out the decay portion of the tooth an filled with synthetic mate ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Lentiviral Vector for the treatment of Fanconi Anemia
SBC: Rimedion, Inc. Topic: NHLBIDESCRIPTIONprovided by applicantIn this Phase II STTR application Rimedion seeks to commercialize a novel treatment for patients suffering from Fanconi anemia and request funding for a Phase I II clinical trialThe product will utilize a HIVbased lentiviral vector expressin the Fanconi anemia A proteinThe strong scientific support for this approached is strengthened by a successful Phase I STTRThe ...
STTR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health -
Wearable Ultralow Power Personal Exposure Monitor for Atmospheric Pollutants
SBC: KWJ ENGINEERING INC Topic: NIEHSDESCRIPTION provided by applicant The goal of this STTR Phase I collaboration between KWJ Engineering KWJ and North Carolina State University NCSU will be development of a unique autonomously powered wearable environmental gas sensor for personal exposure monitoring PEM The approach will be to integrate KWJ ultralow power high performance printed amperometric gas sensor for key atmosp ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
A new treatment for NSAID-associated gastrointestinal damage
SBC: Anteana Therapeutics Inc Topic: NIDDKDESCRIPTION provided by applicant Non steroidal anti inflammatory drugs NSAIDs are among the most widely consumed pharmaceuticals but their prolonged use causes gastric injury and damage to the small intestine Previous work has shown that anandamide an endogenous endocannabinoid substance produced in the gastrointestinal GI mucosa plays an important role in epithelial homeostasis and re ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Protein Sequencing Tools for Biological Therapeutics
SBC: PROTEIN METRICS INC Topic: 400DESCRIPTION provided by applicant Mass spectrometry has become a method of choice for identifying and characterizing small quantities of proteins in complex mixtures However the ability to perform the identification in a high throughput fashion has depended on the availability of high quality protein sequence databases This means that proteins from organisms with unsequenced or poorly sequen ...
STTR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health